Cholesterol and phytosterols differentially regulate the expression of caveolin 1 and a downstream prostate cell growth-suppressor gene

Cancer Epidemiology

Volumn 34, Issue 4, 2010, Pages 461-471

  Ifere, Godwin O ^a   Equan, Anita ^a   Gordon, Kereen ^a   Nagappan, Peri ^a   Igietseme, Joseph U ^b   Ananaba, Godwin A ^a  

^a CLARK ATLANTA UNIVERSITY   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Apoptosis; Biomarkers; Caveolin 1; Chemoprevention; Cholesterol; Growth suppressor; NDRG1; Phytosterols; Prostate cancer; Sterols

Indexed keywords

CASPASE 3; CAVEOLIN 1; CHOLESTEROL; PHYTOSTEROL; TUMOR MARKER; CAV1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; MESSENGER RNA; N-MYC DOWNSTREAM-REGULATED GENE 1 PROTEIN; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CAVEOLIN 1 GENE; CELL VIABILITY; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NDRG1 GENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; CELL PROLIFERATION; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CAVEOLIN 1; CELL CYCLE PROTEINS; CELL PROLIFERATION; CHOLESTEROL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PHYTOSTEROLS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 77955089795     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.04.009     Document Type: Article

References (61)

1. Brand T.C., Hernandez J., Canby-Hagino E.D., Basler J.W., Thompson I.M. Prostate cancer detection strategies. Curr Urol Rep 2006, 7(3):181-185.
2. Segev Y., Nativ O. Nutrition and pharmacological treatment for prevention of prostate cancer. Harefuah 2006, 145(1):47-51.
3. Hsing A.W., Chokkalingam A.P. Prostate cancer epidemiology. Front Biosci 2006, 11:1388-1413.
4. Swinnen J.V., Heemers H., van de Sande T., de Schrijver E., Brusselmans K., Heyns W., et al. Androgens, lipogenesis and prostate cancer. J Steroid Biochem Mol Biol 2004, 92(4):273-279.
5. Caruso R.P., Levinson B., Melamed J., Wieczorek R., Taneja S., Polsky D., et al. Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with Caucasian prostate cancer patients. Clin Cancer Res 2004, 10(1):222-227.
6. Petrovics G., Zhang W., Makarem M., Street J.P., Connely R., Sun L., et al. Elevated expression of PCGEM, a prostate-specific gene with cell growth-promoting function, is associated with high risk prostate cancer patients. Oncogene 2004, 23(2):605-611.
7. Zhuang L., Kim J., Adam R.M., Solomon K.R., Freeman M.R. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 2005, 115(4):959-968.
8. Li L., Ren C.H., Tahir S.A., Ren C., Thompson T.C. Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol Cell Biol 2003, 23(24):9389-9404.
9. Li S., Couet J., Lisanti M.P. Src tyrosine kinases, G alpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 1996, 271(46):29182-29190.
10. Yang G., Truong L.D., Wheeler T.M., Thompson T.C. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res 1999, 59(22):5719-5723.
11. Yang G., Addai J., Ittmann M., Wheeler T.M., Thompson T.C. Elevated caveolin-1 levels in African-American versus white-American prostate cancer. Clin Cancer Res 2000, 6(9):3430-3433.
12. Toselli M., Biella G., Taglietti V., Cazzaniga E., Parenti M. Caveolin-1 expression and membrane cholesterol content modulate N-type calcium channel activity in NG108-15 cells. Biophys J 2005, 89(4):2443-2457.
13. Jiang Y., Li Y., Ke M., Tseng T., Tang Y., Huang M., et al. Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis. Cancer Cell Int 2007, 7(1):1-10.
14. Frank P.G., Cheung M.W.C., Pavlides S., Llaverias G., Park D.S., Lisanti M.P. Caveolin-1 and regulation of cellular cholesterol homeostasis. Am J Physiol Heart Circ Physiol 2006, 291(2):677-686.
15. Homma Y., Kondo Y., Kaneko M., Kitamura T., Nyou W.T., Yanagisawa M., et al. Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate. Carcinogenesis 2004, 25(6):1011-1014.
16. Bist A., Fielding C.J., Fielding P.E. P53 regulates caveolin gene transcription, cell cholesterol and growth by a novel mechanism. Biochemistry 2000, 39(8):1966-1972.
17. Chen K., Albano A., Ho A., Keaney J.K. Activation of p53 by oxidative stress involves platelet-derived growth factor-β receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation. J Biol Chem 2003, 278(41):39527-39533.
18. WAF1/Cip1-dependent mechanism. Mol Biol Cell 2001, 12(8):2229-2244.
19. Freeman M.R., Solomon K.R. Cholesterol and prostate cancer. J Cell Biochem 2004, 91(1):54-69.
20. Brown D.A., London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 2000, 275(23):17221-17224.
21. Li X., Momsen M.M., Brockman H.L., Brown R.E. Sterol structure and sphingomyelin acyl chain length modulate lateral packing elasticity and detergent solubility in model membranes. Biophys J 2003, 85(6):3788-3801.
22. Daniel E.E., El-Yazbi A., Cho W.J. Caveolae and calcium handling, a review and a hypothesis. J Cell Mol Med 2006, 10(2):529-544.
23. Williams T.M., Lisanti M.P. The caveolin genes: from cell biology to medicine. Ann Med 2004, 36(8):584-595.
24. Cohen A.W., Hnasko R., Schubert W., Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol Rev 2004, 84(4):1341-1379.
25. Razandi M., Alton G., Pedram A., Ghonshani S., Webb P., Levin E.R. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol Cell Biol 2003, 23(5):1633-1646.
26. Lu M.L., Schneider M.C., Zheng Y., Zhang X., Richie J.P. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001, 276(16):13442-13451.
27. Bruggers C.S., Fults D., Perkins S.L., Coffin C.M., Carroll W.L. Coexpression of genes involved in apoptosis in central nervous system neoplasms. Pediatr Hematol Oncol 1999, 21(1):19-25.
28. Awad A.B., Chan K.C., Downie A.C., Fink C.S. Peanuts as a source of β-sitosterol, a sterol with anticancer properties. Nutr Cancer 2000, 36(2):238-241.
29. Awad A.B., Fink C.S. Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr 2000, 130(9):2127-2130.
30. Awad A.B., Williams H., Fink C.S. Effect of phytosterols on cholesterol metabolism and MAP kinase in MDA-MB-231 human breast cancer cells. J Nutr Biochem 2003, 14(2):111-119.
31. Greenberg-Ofrath N., Terespolosky Y., Kahane I., Bar R. Cyclodextrins as carriers of cholesterol and fatty acids in cultivation of mycoplasmas. Appl Environ Microbiol 1993, 59(2):547-551.
32. Ifere G.O., Barr E., Equan A., Gordon K., Singh U.P., Chaudhary J., et al. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis, and expression of a prostate-specific gene in prostate cancer cell lines. Cancer Detect Prev 2009, 32(4):319-328.
33. Yalcin A. Quantification of thioredoxin mRNA expression in the rat hippocampus by real-time PCR following oxidative stress. Acta Biochim Pol 2004, 51(4):1059-1065.
34. Fernandez-Alnemri T., Litwack G., Alnemri E.S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994, 269(49):30761-30764.
35. Bishop O.N. Statistics for Biology 1985, Longman (EF) Ltd., London. Microcomputer edition.
36. Campling B.G., Pym J., Galbraith P.R., Cole S.P. Use of MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leuk Res 1988, 12(10):823-831.
37. Jover R., Ponsoda X., Castell J.V., Gomez-Lechion M.J. Acute cytotoxicity of ten chemicals in human and rat cultured hepatocytes and in cell lines: correlation between in vitro data and human lethal concentrations. Toxicol In Vitro 1994, 8(1):47-54.
38. Corban-Weilhelm H., Ehemann V., Becker G., Greulich D., Braun K., Debus J. Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy. Cancer Gene Ther 2004, 11(3):208-214.
39. Awad A.B., Fink C.S., Williams H., Kim U. In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells. Eur J Cancer Prev 2001, 10(6):507-513.
40. Ratnayake W.M.N., LAbbe M.R., Mueller R., Hayward S., Plouffe L., Hollywood R., et al. Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hytpertensive rats. J Nutr 2000, 130(5):1166-1178.
41. Field F.J., Born E., Mathur S.N. Effect of micellar β-sitosterol on cholesterol metabolism in CaCo-2 cells. J Lipid Res 1997, 38(2):348-360.
42. Okuda T., Higashi Y., Kokame K., Tanaka C., Kondoh H., Miyata T. Ndrg1-deficient mice exhibit a progressive demyelination disorder of peripheral nerves. Mol Cell Biol 2004, 24(9):3949-3956.
43. Cangul H. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 2004, 5(27):1-11.
44. Lachat P., Shaw P., Gebhard S., van Belzen N., Chaubert P., Bosman F.T. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 2002, 118(5):399-408.
45. Ando T., Ishiguro H., Kimura M., Mitsui A., Kurehara H., Sugito N., et al. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus 2006, 19(6):454-458.
46. Fiucci G., Ravid D., Reich R., Liscovitch M. Caveoilin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 2002, 21(15):2365-2375.
47. Nasu Y., Timme T.L., Yang G., Bangma C.H., Li L., Ren C., et al. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med 1998, 4(9):1062-1064.
48. Li L., Yang G., Ebara S., Satoh T., Nasu Y., Timme T.L., et al. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res 2001, 61(11):4386-4392.
49. Allen J.A., Yu J.Z., Dave R.H., Bhatnagar A., Roth B.L., Rasenick M.M. Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/Adenylyl cyclase signaling. Mol Pharmacol 2009, 76(5):1082-1093.
50. Park J.H., Han H.J. Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: involvement of PI3K/Akt and ERK. Am J Cell Physiol 2009, 297(4):C935-C944.
51. Volonte D., Liu Y., Galbiati F. The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. FASEB J 2005, 19(2):237-239.
52. Mason R.P., Jacob R.F. Membrane microdomains and vascular biology emerging role in atherogenesis. Circulation 2003, 107(17):2270-2273.
53. Williams T.M., Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005, 288(3):C494-C506.
54. Westerlund S., Laukkanen M.O., Alakuijala P., Turunen P., Yla-Herttuala S. Cholesterol increases DNA methylation in rabbit tissues. Atherosclerosis 2000, 151(1):111-112.
55. Seth G., Ozturk M., Hu W.S. Reverting cholesterol auxotrophy of NSO cells by altering epigenetic gene silencing. Biotechnol Bioeng 2006, 93(4):820-827.
56. Zhang J., Chen S., Zhang W., Zhang J., Liu X., Shi H., et al. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on core promoter region. Gene 2008, 417(1-2):5-12.
57. Gargalovic P., Dory L. Cellular apoptosis is associated with increased caveolin-1 expression in macrophages. J Lipid Res 2003, 44(9):1622-1632.
58. Stein S., Thomas E.K., Herzog B., Westfall M.D., Rocheleau J.V., Jackson R.S., et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Sci 2004, 279(47):48930-48940.
59. Von Holtz R.L., Fink C.S., Awad A.B. β-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCap human prostate cancer cells. Nutr Cancer 1998, 32(1):8-12.
60. Volonte D., Zhang K., Lisanti M.P., Galbiati F. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts: stress-induced premature senescence upregulates the expression of endogenous caveolin-1. Mol Biol Cell 2002, 13(7):2502-2517.
61. Taylor W.R., DePrimo S.E., Agarwal A., Agarwal M.L., Schonthal A.H., Katula K.S., et al. Mechanisms of G2 arrest in response to overexpression of p53. Mol Biol Cell 1999, 10(11):3607-3622.